Current research into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are showing encouraging effects in managing excess mass and related second-type condition. Animal data suggest a distinct mechanism https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/